Miguel Santin

9PUBLICATIONS
43CO-AUTHORS
Nanotoxicology, health and safetyMedical biotechnology diagnostics (incl. biosensors)Epidemiological methodsAutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 05, 2025
Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country.

Sandra Pérez-Recio, Maria D Grijota-Camino, Jordi Guardiola

|Aug 30, 2023
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.

Sandra Pérez-Recio, Maria D Grijota-Camino, Luis Anibarro

|Oct 21, 2022
Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).

Miguel Santin, Sandra Perez-Recio, Maria D Grijota

|Nov 10, 2021
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.

Sandra Pérez-Recio, Natàlia Pallarès, Maria D Grijota-Camino

|Oct 30, 2020
Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review.

Miguel Santin, Cristina Escrich, Carles Majòs

|Jul 09, 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Charles L Daley, Jonathan M Iaccarino, Christoph Lange

Pageof 2

Frequent Collaborators

2 joint publications

Sandra Pérez-Recio

2 joint publications

Luis Anibarro

1 joint publications

Fernando Salvador

1 joint publications

Carme Muñoz